The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Coding Corner Answer: Billing for an Inflectra Infusion

Rheumatology Coding Corner Answer: Billing for an Inflectra Infusion

May 17, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Take the challenge.

You Might Also Like
  • Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier
  • Rheumatology Coding Corner Answer: Physical Examination with Infliximab Infusion
  • Rheumatology Coding Corner Answer: Medical Chart Review of an Infliximab Infusion
Explore This Issue
May 2018
Also By This Author
  • Email & Text in the World of HIPAA

CPT codes: 96413, 96415, 96375, Q5103x20, J1200
ICD-10: M07.9

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Coding Rationale

hxdbzxy; Anna Jurkovska / shutterstock.com

hxdbzxy; Anna Jurkovska / shutterstock.com

This procedure is billed with CPT code 96413 for the initial hour of the intravenous infusion and CPT code 96415 for each additional hour. The patient was given 50 mg of diphenhydramine prior to the infusion to prevent reactions and should be billed with CPT 96375, because only one initial drug administration code can be billed on the same date of service.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Based on guidance from the Centers for Medicare & Medicaid Services (CMS), effective April 1, 2018, HCPCS code Q5103 should be used when submitting claims for infliximab-dyyb, and the NDC is 00069=0809-xx. Bill for the units of Inflectra at 10 mg X 20 (two vials = 200 mg).

Keep in mind, an evaluation and management (E/M) service is not billed with this visit because there is no medical necessity according to the documentation guidelines to code for an E/M visit. The service would not be separately reimbursed, because there is no significant, separately identifiable work performed by the provider.

For questions or additional information on coding and documentation guidelines, contact Melesia Tillman, CPC-I, CPC, CRHC, CHA, via email at [email protected] or call 404-633-3777 x820.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Billing/Coding, From the College, Practice Management Tagged With: Billing & Coding, INFLECTRA (infliximab-dyyb)Issue: May 2018

You Might Also Like:
  • Rheumatology Coding Corner Answer: Billing Infusion Procedure with JW Modifier
  • Rheumatology Coding Corner Answer: Physical Examination with Infliximab Infusion
  • Rheumatology Coding Corner Answer: Medical Chart Review of an Infliximab Infusion
  • Coding Corner Answer: How to Bill a Rituximab Infusion Visit?

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)